Replies to post #166677 on NorthWest Biotherapeutics Inc (NWBO)

[Rootjim]

With the DCVax-L trial winding down. The last estimated monthly operating cost for NWBO was about 1 million per month. The 500,000 thousand dollars per month income should help put NWBO on sound financial footing. If the proxy passes NWBO should have enough funds to operate for years. NWBO investors are passive investors so they do not need to do anything, but be patient. Good news could be today or 10 years away. Who knows ? IMO